Mechanisms of testosterone deficiency-related endothelial dysfunction: Invited commentary for the Hellenic Journal of Cardiology on: Tsikas et al. "Associations between asymmetric dimethylarginine, nitrite-dependent renal carbonic anhydrase activity and plasma testosterone levels in hypogonadal men".

Citation data:

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, ISSN: 2241-5955, Vol: 59, Issue: 4, Page: 207-208

Publication Year:
2018
Captures 1
Readers 1
Social Media 18
Shares, Likes & Comments 16
Tweets 2
PMID:
29890281
DOI:
10.1016/j.hjc.2018.06.001
Author(s):
Antonopoulos, Alexios S; Antoniades, Charalambos
Publisher(s):
Elsevier BV
Tags:
Medicine
Most Recent Tweet View All Tweets
article description
Evidence from clinical studies suggests that patients with low testosterone levels are at increased cardiovascular disease risk. Even though the exact mechanisms remain poorly understood, a low plasma testosterone level is associated with a pro-atherogenic lipid profile, insulin resistance and increased levels of pro-inflammatory mediators and vascular dysfunction, which is typically observed in patients with hypogonadism. Furthermore, recent evidence suggests that testosterone deficiency has also direct adverse effects on the endothelium and nitric oxide (NO) bioavailability. Observations from studies in patients with hypogonadal hypogonadism imply that the mechanisms of endothelial dysfunction related to testosterone deficiency may involve changes in asymmetric dimethylarginine (ADMA) levels, a known endogenous inhibitor of NO synthase. Evidence suggests that testosterone replacement therapy is not only a safe but also an effective means to reduce atherosclerotic risk and reverse endothelial dysfunction in patients with hypogonadal hypogonadism. Further research in the field is expected to clarify whether changes in ADMA metabolism constitute the central mechanism through which a low testosterone level leads to endothelial dysfunction.